购物车
- 全部删除
- 您的购物车当前为空
CTSL/CAPN1-IN-2 (Compound 14b) 是一种口服活性抑制剂,针对CTSL和CAPN1,其IC50值分别为6.88 nM和347.6 nM。该化合物展示了抗炎作用和良好的药代动力学属性。此外,CTSL/CAPN1-IN-2 通过阻断病毒入侵,表现出对冠状病毒的广谱抗病毒活性。
CTSL/CAPN1-IN-2 (Compound 14b) 是一种口服活性抑制剂,针对CTSL和CAPN1,其IC50值分别为6.88 nM和347.6 nM。该化合物展示了抗炎作用和良好的药代动力学属性。此外,CTSL/CAPN1-IN-2 通过阻断病毒入侵,表现出对冠状病毒的广谱抗病毒活性。
规格 | 价格 | 库存 | 数量 |
---|---|---|---|
10 mg | 询价 | 10-14周 | |
50 mg | 询价 | 10-14周 |
产品描述 | CTSL/CAPN1-IN-2 (Compound 14b) serves as an orally active inhibitor targeting both CTSL and CAPN1, manifesting IC50 values of 6.88 nM for CTSL and 347.6 nM for CAPN1 respectively. This compound not only displays anti-inflammatory attributes but also features favorable pharmacokinetic properties. Moreover, CTSL/CAPN1-IN-2 shows extensive antiviral effects against coronaviruses by inhibiting viral entry [1]. |
分子量 | 600.7 |
分子式 | C34H40N4O6 |
CAS No. | 2410075-64-6 |
存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
版权所有©2015-2024 TargetMol Chemicals Inc.保留所有权利.
评论内容